Iqvia, Flagship Pioneering announce strategic collaboration

IQVIA (IQV) and Flagship Pioneering, the bioplatform innovation company, announced a strategic collaboration to accelerate the development of breakthrough life sciences companies. The collaboration will help the Flagship ecosystem of biopharma companies accelerate innovation by offering access to IQVIA’s comprehensive capabilities including unparalleled information assets, analytics and domain expertise across the drug development life cycle from discovery through early development and commercialization. The collaboration will utilize IQVIA’s cutting-edge technologies in the areas of artificial intelligence, analytics and clinical trial design and execution to create a more seamless, efficient and effective approach to drug development and early commercial viability for Flagship’s ecosystem of companies. The work will center on three service areas: drug development strategy and analytics, clinical development, and asset valuation and due diligence.